Comparative Effectiveness of Treatments for Open-Angle Glaucoma: A Systematic Review for the U.S. Preventive Services Task Force

BACKGROUND Glaucoma is an acquired degeneration of the optic nerve and a leading cause of blindness worldwide. Medical and surgical treatments that decrease intraocular pressure may prevent visual impairment and blindness. PURPOSE To compare the effectiveness of medical, laser, and surgical treatments in adults with open-angle glaucoma with regard to decreasing intraocular pressure and preventing optic nerve damage, vision loss, and visual impairment. DATA SOURCES MEDLINE, CENTRAL, and an existing database for systematic reviews (through 2 March 2011); MEDLINE, EMBASE, LILACS, and CENTRAL for primary studies (through 30 July 2012). STUDY SELECTION English-language systematic reviews; randomized, controlled trials; and quasi-randomized, controlled trials for most outcomes and observational studies for quality of life and harms. DATA EXTRACTION Two investigators abstracted or checked information about study design, participants, and outcomes and assessed risk of bias and strength of evidence. DATA SYNTHESIS High-level evidence suggests that medical, laser, and surgical treatments decrease intraocular pressure and that medical treatment and trabeculectomy reduce the risk for optic nerve damage and visual field loss compared with no treatment. The direct effect of treatments on visual impairment and the comparative efficacy of different treatments are not clear. Harms of medical treatment are primarily local (ocular redness, irritation); surgical treatment carries a small risk for more serious complications. LIMITATION Heterogeneous outcome definitions and measurements among the included studies; exclusion of many treatment studies that did not stratify results by glaucoma type. CONCLUSION Medical and surgical treatments for open-angle glaucoma lower intraocular pressure and reduce the risk for optic nerve damage over the short to medium term. Which treatments best prevent visual disability and improve patient-reported outcomes is unclear.

[1]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[2]  C. Allaire,et al.  Latanoprost 0.005% Test Formulation is as Effective as Xalatan® in Patients with Ocular Hypertension and Primary Open-Angle Glaucoma , 2012, European journal of ophthalmology.

[3]  M. Cucherat,et al.  Efficacy and Tolerability of Prostaglandin Analogs: A Meta-analysis of Randomized Controlled Clinical Trials , 2008, Journal of glaucoma.

[4]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[5]  Michael V. Boland,et al.  Treatment for Glaucoma: Comparative Effectiveness , 2012 .

[6]  R. Schiffman,et al.  Fixed-combination brimonidine–timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study , 2012, Current medical research and opinion.

[7]  R. Wormald,et al.  Intra-operative mitomycin C for glaucoma surgery. , 2001, The Cochrane database of systematic reviews.

[8]  E. E. Hartmann,et al.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. , 2002, Archives of ophthalmology.

[9]  R W Flower,et al.  The mechanism of optic nerve damage in experimental acute intraocular pressure elevation. , 1980, Investigative ophthalmology & visual science.

[10]  Valter Torri,et al.  Results of the European Glaucoma Prevention Study. , 2005, Ophthalmology.

[11]  P. Lichter,et al.  Fear of blindness in the Collaborative Initial Glaucoma Treatment Study: patterns and correlates over time. , 2007, Ophthalmology.

[12]  M. C. Leske,et al.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. , 2002, Archives of ophthalmology.

[13]  J. Craig,et al.  Meta‐analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma , 2008, Clinical & experimental ophthalmology.

[14]  E. Campos,et al.  An Evaluation of Therapeutic Noninferiority of 0.005% Latanoprost Ophthalmic Solution and Xalatan in Patients With Glaucoma or Ocular Hypertension , 2013, Journal of glaucoma.

[15]  J. Kirwan,et al.  Beta radiation for glaucoma surgery. , 2012, The Cochrane database of systematic reviews.

[16]  Laser trabeculoplasty for open angle glaucoma. , 2007, The Cochrane database of systematic reviews.

[17]  A. Avenell,et al.  Medical versus surgical interventions for open angle glaucoma. , 2012, The Cochrane database of systematic reviews.

[18]  H. Quigley,et al.  The number of people with glaucoma worldwide in 2010 and 2020 , 2006, British Journal of Ophthalmology.

[19]  G. Antes,et al.  Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials , 2005, BMJ : British Medical Journal.

[20]  R. P. Mills,et al.  The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. , 2001, Ophthalmology.

[21]  W. C. Stewart,et al.  Incidence of Conjunctival Exposure following Drainage Device Implantation in Patients with Glaucoma , 2010, European journal of ophthalmology.

[22]  E. Roughead,et al.  Managing Glaucoma in those with Co-morbidity: Not as Easy as it Seems , 2012, Ophthalmic epidemiology.

[23]  C. Bunce,et al.  Post-operative 5-Fluorouracil for glaucoma surgery. , 2001, The Cochrane database of systematic reviews.

[24]  R. Ritch,et al.  A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. , 2011, American journal of ophthalmology.

[25]  Jennifer S. Lin,et al.  Using Existing Systematic Reviews in Complex Systematic Reviews , 2008, Annals of Internal Medicine.

[26]  O Findl,et al.  Medical interventions for primary open angle glaucoma and ocular hypertension. , 2007, The Cochrane database of systematic reviews.

[27]  J. Cox,et al.  Efficacy of antiglaucoma fixed combination therapy versus unfixed components in reducing intraocular pressure: a systematic review , 2008, British Journal of Ophthalmology.

[28]  J. Craig,et al.  Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma , 2006, British Journal of Ophthalmology.

[29]  Douglas K Owens,et al.  AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. , 2010, Journal of clinical epidemiology.

[30]  Jin-wei Cheng,et al.  Meta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressure. , 2008, Clinical therapeutics.

[31]  C. Richter.  Laser Trabeculoplasty for Open-Angle Glaucoma , 2020, Albert and Jakobiec's Principles and Practice of Ophthalmology.

[32]  Xiaoming Chen,et al.  Travoprost compared with other prostaglandin analogues or timolol in patients with open‐angle glaucoma or ocular hypertension: meta‐analysis of randomized controlled trials , 2006, Clinical & experimental ophthalmology.

[33]  Y. Buys,et al.  Meta-analysis of 1- versus 2-Site Phacotrabeculectomy. , 2011, Ophthalmology.

[34]  S. Loon,et al.  Meta-analysis of Viscocanalostomy Versus Trabeculectomy in Uncontrolled Glaucoma , 2010, Journal of glaucoma.

[35]  W. Hodge,et al.  The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review , 2007, British Journal of Ophthalmology.

[36]  Jin-wei Cheng,et al.  Efficacy and Tolerability of Nonpenetrating Filtering Surgery in the Treatment of Open-Angle Glaucoma: A Meta-Analysis , 2009, Ophthalmologica.

[37]  Michael V. Boland,et al.  Screening for Glaucoma: Comparative Effectiveness , 2012 .

[38]  V. Polo,et al.  Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials , 2008, British Journal of Ophthalmology.

[39]  H. Dua,et al.  Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension , 2001, The British journal of ophthalmology.

[40]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[41]  A. Sommer,et al.  Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. , 1991, Archives of ophthalmology.

[42]  J. Nachega,et al.  Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis , 2009, Clinical ophthalmology.

[43]  M. C. Leske,et al.  Treatment and vision-related quality of life in the early manifest glaucoma trial. , 2005, Ophthalmology.